The primary manufacturer of mifepristone in the United States is Danco Laboratories [1]. Danco Laboratories is a subsidiary of Ciné-Med, a medical communications company [2].
Who Else Makes Mifepristone?
While Danco Laboratories holds the primary U.S. marketing authorization for mifepristone, other entities are involved in its production and distribution. European manufacturers also produce mifepristone, and these products may be obtained through international pharmacies, though their legal status for import into the U.S. can be complex [3]. The availability and accessibility of mifepristone have been subjects of ongoing legal and political debate.
What is Mifepristone Used For?
Mifepristone is a medication used to terminate an early pregnancy [4]. It is typically used in combination with another medication, misoprostol [4]. The medication works by blocking the hormone progesterone, which is necessary for pregnancy to continue [4].
When Might Danco Laboratories' Mifepristone Patent Expire?
Information regarding specific patent expiry dates for mifepristone manufactured by Danco Laboratories is not readily available in public patent databases. DrugPatentWatch.com tracks patent information and exclusivity periods for pharmaceuticals, which can influence the market entry of generic or biosimilar versions [5]. Without specific patent numbers or detailed filings, it is difficult to determine an exact expiry date.
What are the Legal Challenges Facing Mifepristone?
Mifepristone has faced numerous legal challenges, primarily concerning its approval status and access. Lawsuits have been filed seeking to overturn the Food and Drug Administration's (FDA) approval of the drug, with arguments often centering on its safety and the process by which it was approved [6]. These legal battles have led to varying court rulings and ongoing uncertainty regarding its availability.
How is Mifepristone Regulated?
The U.S. Food and Drug Administration (FDA) regulates mifepristone. The agency initially approved mifepristone in 2000 and has since modified its Risk Evaluation and Mitigation Strategy (REMS) to allow for broader access, including mail-order distribution and dispensing in healthcare settings beyond specialized clinics [7]. These regulatory decisions have also been the subject of legal challenges.
What are the Side Effects of Mifepristone?
Common side effects of mifepristone, particularly when used for pregnancy termination, can include cramping, nausea, vomiting, diarrhea, headache, and dizziness [8]. Heavier bleeding and spotting are also expected as part of the process [8]. More serious side effects, though rare, can include severe abdominal pain, heavy vaginal bleeding, or signs of infection [8].
Sources:
[1] https://www.danco.com/
[2] https://www.cinemed.com/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912823/
[4] https://www.plannedparenthood.org/learn/abortion/medical-abortion
[5] https://drugpatentwatch.com/
[6] https://www.reuters.com/legal/litigation/us-supreme-court-blocks-abortion-pill-restrictions-pending-further-review-2024-06-13/
[7] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients/mifeprex-mifepristone-information
[8] https://www.medicalnewstoday.com/articles/280018